Health-related quality of life in patients with glioblastoma: a randomised controlled trial (Q40368396)

19 September 2017

title

Health-related quality of life in patients with glioblastoma: a randomised controlled trial (English)

1 reference

National Cancer Institute of Canada Clinical Trials Group

19 September 2017

1 reference

1 reference

15

object named as

National Cancer Institute of Canada Clinical Trials Group

1 reference

19 September 2017

12

Andrew Bottomley

1 reference

19 September 2017

Martin J B Taphoorn

1

1 reference

19 September 2017

Roger Stupp

2

1 reference

19 September 2017

Corneel Coens

3

1 reference

19 September 2017

David Osoba

4

1 reference

19 September 2017

Rolf Kortmann

5

1 reference

19 September 2017

Martin J van den Bent

6

1 reference

19 September 2017

Warren Mason

7

1 reference

19 September 2017

René O Mirimanoff

8

1 reference

19 September 2017

Brigitta G Baumert

9

1 reference

19 September 2017

Elizabeth Eisenhauer

10

1 reference

19 September 2017

Peter Forsyth

11

1 reference

19 September 2017

European Organisation for Research and Treatment of Cancer Brain Tumour Group

13

1 reference

19 September 2017

EORTC Radiotherapy Group

14

1 reference

19 September 2017

publication date

1 December 2005

1 reference

Lancet Oncology Commission

19 September 2017

published in

1 reference

19 September 2017

volume

6

1 reference

19 September 2017

issue

12

1 reference

19 September 2017

page(s)

937-944

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

19 September 2017

1 reference

7 January 2021

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Current and future developments in the use of temozolomide for the treatment of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Epileptic seizures during follow-up of patients treated for primary brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

The challenges of long-term treatment outcomes in adults with malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

Cognitive deficits in adult patients with brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970432-0

7 January 2021

10.1016/S1470-2045(05)70432-0

Identifiers

DOI

1 reference

19 September 2017

1 reference